In this study, the safety and efficacy of buntanetap will be assessed in a diverse population of early AD participants via a randomized, double-blind, placebo-controlled, multicenter Phase 3 trial.
The purpose of this research is to learn if the experimental study drug KarXT + KarX-EC works to treat thinking and memory problems as well as improve overall function in people with Alzheimer’s disease (AD).
Dr. Pandey will be able to push forward her dissertation project, which investigates how aryl hydrocarbon receptor signaling can protect and repair inner-ear hair cells damaged by noise or medication for further research.
Dr. Pandey will be able to push forward her dissertation project, which investigates how aryl hydrocarbon receptor signaling can protect and repair inner-ear hair cells damaged by noise or medication for further research.
Dr. Pandey will be able to push forward her dissertation project, which investigates how aryl hydrocarbon receptor signaling can protect and repair inner-ear hair cells damaged by noise or medication for further research.
Dr. Pandey will be able to push forward her dissertation project, which investigates how aryl hydrocarbon receptor signaling can protect and repair inner-ear hair cells damaged by noise or medication for further research.
Dr. Pandey will be able to push forward her dissertation project, which investigates how aryl hydrocarbon receptor signaling can protect and repair inner-ear hair cells damaged by noise or medication for further research.
Dr. Pandey will be able to push forward her dissertation project, which investigates how aryl hydrocarbon receptor signaling can protect and repair inner-ear hair cells damaged by noise or medication for further research.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
Dr. Ruchika Goel is the inaugural recipient of the O.H. Wesly Endowed Chair of Excellence in Hematologic Disorders. The investiture ceremony on August 26 honored both Goel’s remarkable career as a physician-scientist and the enduring legacy of Dr. Wesly, whose generosity made the endowment possible.
